Immunological Non-inferiority Between Two Process-manufactured Influenza Vaccines in Adults Aged 18 to 60 Years.
Phase of Trial: Phase III
Latest Information Update: 01 Oct 2016
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Pharmacodynamics; Registrational
- Sponsors GlaxoSmithKline
- 21 Dec 2010 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
- 18 Nov 2010 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 03 Nov 2009 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.